Please use this identifier to cite or link to this item: https://accedacris.ulpgc.es/jspui/handle/10553/156306
DC FieldValueLanguage
dc.contributor.authorVolz, Eriken_US
dc.contributor.authorMishra, Swapnilen_US
dc.contributor.authorChand, Meeraen_US
dc.contributor.authorBarrett, Jeffrey C.en_US
dc.contributor.authorJohnson, Roberten_US
dc.contributor.authorGeidelberg, Lilyen_US
dc.contributor.authorHinsley, Wes R.en_US
dc.contributor.authorLaydon, Daniel J.en_US
dc.contributor.authorDabrera, Gavinen_US
dc.contributor.authorO’Toole, Áineen_US
dc.contributor.authorAmato, Roberten_US
dc.contributor.authorRagonnet-Cronin, Manonen_US
dc.contributor.authorHarrison, Ianen_US
dc.contributor.authorJackson, Benen_US
dc.contributor.authorAriani, Cristina V.en_US
dc.contributor.authorBoyd, Oliviaen_US
dc.contributor.authorLoman, Nicholas J.en_US
dc.contributor.authorMcCrone, John T.en_US
dc.contributor.authorGonçalves, Sóniaen_US
dc.contributor.authorJorgensen, Daviden_US
dc.contributor.authorMyers, Richarden_US
dc.contributor.authorHill, Verityen_US
dc.contributor.authorJackson, David K.en_US
dc.contributor.authorGaythorpe, Katyen_US
dc.contributor.authorGroves, Natalieen_US
dc.contributor.authorSillitoe, Johnen_US
dc.contributor.authorKwiatkowski, Dominic P.en_US
dc.contributor.authorFlaxman, Sethen_US
dc.contributor.authorRatmann, Oliveren_US
dc.contributor.authorBhatt, Samiren_US
dc.contributor.authorHopkins, Susanen_US
dc.contributor.authorGandy, Axelen_US
dc.contributor.authorRambaut, Andrewen_US
dc.contributor.authorFerguson, Neil M.en_US
dc.contributor.authorBetancor Quintana, Gilberto Joseen_US
dc.date.accessioned2026-01-28T15:14:12Z-
dc.date.available2026-01-28T15:14:12Z-
dc.date.issued2021en_US
dc.identifier.issn0028-0836en_US
dc.identifier.urihttps://accedacris.ulpgc.es/jspui/handle/10553/156306-
dc.description.abstractThe SARS-CoV-2 lineage B.1.1.7, designated variant of concern (VOC) 202012/01 by Public Health England1, was first identified in the UK in late summer to early autumn 20202. Whole-genome SARS-CoV-2 sequence data collected from community-based diagnostic testing for COVID-19 show an extremely rapid expansion of the B.1.1.7 lineage during autumn 2020, suggesting that it has a selective advantage. Here we show that changes in VOC frequency inferred from genetic data correspond closely to changes inferred by S gene target failures (SGTF) in community-based diagnostic PCR testing. Analysis of trends in SGTF and non-SGTF case numbers in local areas across England shows that B.1.1.7 has higher transmissibility than non-VOC lineages, even if it has a different latent period or generation time. The SGTF data indicate a transient shift in the age composition of reported cases, with cases of B.1.1.7 including a larger share of under 20-year-olds than non-VOC cases. We estimated time-varying reproduction numbers for B.1.1.7 and co-circulating lineages using SGTF and genomic data. The best-supported models did not indicate a substantial difference in VOC transmissibility among different age groups, but all analyses agreed that B.1.1.7 has a substantial transmission advantage over other lineages, with a 50% to 100% higher reproduction number.en_US
dc.languageengen_US
dc.relation.ispartofNatureen_US
dc.sourceNature (eISSN 0028-0836), v. 593, pp. 266-269 (Marzo 2021)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320505 Enfermedades infecciosasen_US
dc.subject320102 Genética clínicaen_US
dc.subject.otherPopulation geneticsen_US
dc.subject.otherSARS-CoV-2en_US
dc.subject.otherViral infectionen_US
dc.titleAssessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in Englanden_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1038/s41586-021-03470-xen_US
dc.description.lastpage269en_US
dc.identifier.issue7858-
dc.description.firstpage266en_US
dc.relation.volume593en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.notas*Miembro de COVID-19 Genomics UK (COG-UK) consortiumen_US
dc.description.numberofpages4en_US
dc.utils.revisionen_US
dc.date.coverdateMarzo 2021en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr17,897
dc.description.jcr69,504
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
dc.description.miaricds11,0
dc.description.erihplusERIH PLUS
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Trypanosomosis, Resistencia a Antibióticos, Virología y Medicina Animal-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0003-0548-7690-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameBetancor Quintana, Gilberto Jose-
Appears in Collections:Artículos
Show simple item record

WEB OF SCIENCETM
Citations

818
checked on Feb 22, 2026

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.